Press Releases Sedana Medical AB

Equities

Delayed Nasdaq Stockholm Other stock markets 15:18:17 28/06/2024 BST			5-day change	1st Jan Change
23.15 ^SEK	-1.49%		-6.46%	-0.04%

05-29	Sedana Medical AB Completes Patient Recruitment for its Clinical Program in the US	CI
05-22	Sedana Medical AB Approves Election of Jens Viebke and Donna Haire as Board Members	CI

Sedana Medical completes patient recruitment for its clinical program in the US	05-29	AQ
Report from Sedana Medical's annual general meeting on 22 May 2024	05-22	AQ
Sedana Medical Q1 - Set to beat conservative sales target	04-26	AQ
Sedana Medical AB's Interim report January-March 2024	04-25	AQ
Sedana Medical completes patient recruitment for INSPiRE-ICU 1 clinical trial in the US	04-25	AQ
Notice of Annual General Meeting in Sedana Medical	04-22	AQ
Sedana Medical publishes its Annual Report for 2023	04-15	AQ
Invitation to presentation of Sedana Medical's interim report for the first quarter 2024	04-05	AQ
Sedana Medical Q4 - Likely to beat conservative 2024 sales target	02-16	AQ
Sedana Medical AB's Year-end report 2023	02-15	AQ
Invitation to presentation of Sedana Medical's fourth quarter and year-end report for 2023	01-25	AQ
Sedana Medical files submission for paediatric indication	12-20	AQ
Sedana Medical secures data exclusivity and market protection for Sedaconda[®] (isoflurane) until 2031	11-22	AQ
Key results of Sedana Medical's paediatric study IsoCOMFORT published	11-16	AQ
Sedana Medical Q3 - Accelerated geographical expansion up next	30/10/23	AQ
Sedana Medical AB's Interim report January-September 2023	26/10/23	AQ
Sedana Medical's Nomination Committee established	24/10/23	AQ
The SESAR investigator-initiated trial completes patient enrollment	23/10/23	AQ
Sedana Medical receives market approval in the UK	10/10/23	AQ
Invitation to presentation of Sedana Medical's interim report for the third quarter 2023	05/10/23	AQ

No results for this search